| UniProt ID | CSK2B_HUMAN | |
|---|---|---|
| UniProt AC | P67870 | |
| Protein Name | Casein kinase II subunit beta | |
| Gene Name | CSNK2B | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 215 | |
| Subcellular Localization | ||
| Protein Description | Participates in Wnt signaling (By similarity). Plays a complex role in regulating the basal catalytic activity of the alpha subunit.. | |
| Protein Sequence | MSSSEEVSWISWFCGLRGNEFFCEVDEDYIQDKFNLTGLNEQVPHYRQALDMILDLEPDEELEDNPNQSDLIEQAAEMLYGLIHARYILTNRGIAQMLEKYQQGDFGYCPRVYCENQPMLPIGLSDIPGEAMVKLYCPKCMDVYTPKSSRHHHTDGAYFGTGFPHMLFMVHPEYRPKRPANQFVPRLYGFKIHPMAYQLQLQAASNFKSPVKTIR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSSSEEVSW ------CCCHHHHHH | 42.44 | 25159151 | |
| 2 | Acetylation | ------MSSSEEVSW ------CCCHHHHHH | 42.44 | 19369195 | |
| 3 | Phosphorylation | -----MSSSEEVSWI -----CCCHHHHHHH | 40.23 | 25159151 | |
| 4 | Phosphorylation | ----MSSSEEVSWIS ----CCCHHHHHHHH | 30.39 | 25159151 | |
| 8 | Phosphorylation | MSSSEEVSWISWFCG CCCHHHHHHHHHHHC | 23.21 | 19369195 | |
| 11 | Phosphorylation | SEEVSWISWFCGLRG HHHHHHHHHHHCCCC | 14.08 | 20068231 | |
| 33 | Ubiquitination | DEDYIQDKFNLTGLN CHHHHHHHHCCCCHH | 21.56 | - | |
| 37 | Phosphorylation | IQDKFNLTGLNEQVP HHHHHCCCCHHCCCC | 40.50 | 23186163 | |
| 69 | Phosphorylation | LEDNPNQSDLIEQAA HCCCCCHHHHHHHHH | 40.81 | 17192257 | |
| 92 | Methylation | ARYILTNRGIAQMLE HHHHHHHHHHHHHHH | 32.43 | - | |
| 97 | Sulfoxidation | TNRGIAQMLEKYQQG HHHHHHHHHHHHHCC | 3.74 | 21406390 | |
| 100 | Ubiquitination | GIAQMLEKYQQGDFG HHHHHHHHHHCCCCC | 44.38 | - | |
| 100 | Acetylation | GIAQMLEKYQQGDFG HHHHHHHHHHCCCCC | 44.38 | 26051181 | |
| 101 | Phosphorylation | IAQMLEKYQQGDFGY HHHHHHHHHCCCCCC | 9.19 | 28152594 | |
| 108 | Phosphorylation | YQQGDFGYCPRVYCE HHCCCCCCCCEEEEC | 10.16 | 28152594 | |
| 109 | Glutathionylation | QQGDFGYCPRVYCEN HCCCCCCCCEEEECC | 1.45 | 22555962 | |
| 114 | Glutathionylation | GYCPRVYCENQPMLP CCCCEEEECCCCCCC | 3.47 | 22555962 | |
| 131 | Ubiquitination | LSDIPGEAMVKLYCP CCCCCCCHHHHHHCC | 17.62 | - | |
| 134 | Ubiquitination | IPGEAMVKLYCPKCM CCCCHHHHHHCCCCC | 22.21 | - | |
| 136 | Acetylation | GEAMVKLYCPKCMDV CCHHHHHHCCCCCEE | 10.86 | - | |
| 136 | Ubiquitination | GEAMVKLYCPKCMDV CCHHHHHHCCCCCEE | 10.86 | - | |
| 139 | Acetylation | MVKLYCPKCMDVYTP HHHHHCCCCCEEECC | 38.33 | 25825284 | |
| 139 | Ubiquitination | MVKLYCPKCMDVYTP HHHHHCCCCCEEECC | 38.33 | 21890473 | |
| 139 | Ubiquitination | MVKLYCPKCMDVYTP HHHHHCCCCCEEECC | 38.33 | 21890473 | |
| 142 | Phosphorylation | LYCPKCMDVYTPKSS HHCCCCCEEECCCCC | 39.48 | - | |
| 144 | Acetylation | CPKCMDVYTPKSSRH CCCCCEEECCCCCCC | 17.04 | - | |
| 144 | Ubiquitination | CPKCMDVYTPKSSRH CCCCCEEECCCCCCC | 17.04 | - | |
| 144 | Phosphorylation | CPKCMDVYTPKSSRH CCCCCEEECCCCCCC | 17.04 | - | |
| 145 | Phosphorylation | PKCMDVYTPKSSRHH CCCCEEECCCCCCCC | 24.88 | 22817900 | |
| 147 | Ubiquitination | CMDVYTPKSSRHHHT CCEEECCCCCCCCCC | 53.95 | - | |
| 147 | Acetylation | CMDVYTPKSSRHHHT CCEEECCCCCCCCCC | 53.95 | 23749302 | |
| 148 | Phosphorylation | MDVYTPKSSRHHHTD CEEECCCCCCCCCCC | 33.53 | - | |
| 149 | Phosphorylation | DVYTPKSSRHHHTDG EEECCCCCCCCCCCC | 41.58 | - | |
| 175 | Methylation | FMVHPEYRPKRPANQ EECCCCCCCCCCHHH | 28.71 | - | |
| 177 | Ubiquitination | VHPEYRPKRPANQFV CCCCCCCCCCHHHCC | 63.11 | - | |
| 178 | Methylation | HPEYRPKRPANQFVP CCCCCCCCCHHHCCC | 37.94 | - | |
| 183 | Methylation | PKRPANQFVPRLYGF CCCCHHHCCCHHHCC | 9.07 | - | |
| 186 | Methylation | PANQFVPRLYGFKIH CHHHCCCHHHCCEEE | 34.93 | - | |
| 188 | Ubiquitination | NQFVPRLYGFKIHPM HHCCCHHHCCEEECC | 23.07 | - | |
| 191 | Ubiquitination | VPRLYGFKIHPMAYQ CCHHHCCEEECCCHH | 35.42 | - | |
| 195 | Sulfoxidation | YGFKIHPMAYQLQLQ HCCEEECCCHHHHHH | 3.16 | 30846556 | |
| 197 | Phosphorylation | FKIHPMAYQLQLQAA CEEECCCHHHHHHHH | 11.96 | 23927012 | |
| 202 | Phosphorylation | MAYQLQLQAASNFKS CCHHHHHHHHHCCCC | 23.17 | - | |
| 205 | Phosphorylation | QLQLQAASNFKSPVK HHHHHHHHCCCCCCC | 45.90 | 22167270 | |
| 205 | Methylation | QLQLQAASNFKSPVK HHHHHHHHCCCCCCC | 45.90 | - | |
| 205 | Ubiquitination | QLQLQAASNFKSPVK HHHHHHHHCCCCCCC | 45.90 | - | |
| 206 | Phosphorylation | LQLQAASNFKSPVKT HHHHHHHCCCCCCCC | 43.57 | 17081983 | |
| 208 | Ubiquitination | LQAASNFKSPVKTIR HHHHHCCCCCCCCCC | 59.09 | 21890473 | |
| 208 | Ubiquitination | LQAASNFKSPVKTIR HHHHHCCCCCCCCCC | 59.09 | 21890473 | |
| 208 | Methylation | LQAASNFKSPVKTIR HHHHHCCCCCCCCCC | 59.09 | - | |
| 209 | Acetylation | QAASNFKSPVKTIR- HHHHCCCCCCCCCC- | 30.68 | - | |
| 209 | Ubiquitination | QAASNFKSPVKTIR- HHHHCCCCCCCCCC- | 30.68 | - | |
| 209 | Sumoylation | QAASNFKSPVKTIR- HHHHCCCCCCCCCC- | 30.68 | - | |
| 209 | Phosphorylation | QAASNFKSPVKTIR- HHHHCCCCCCCCCC- | 30.68 | 22167270 | |
| 210 | Phosphorylation | AASNFKSPVKTIR-- HHHCCCCCCCCCC-- | 32.01 | - | |
| 212 | Sumoylation | SNFKSPVKTIR---- HCCCCCCCCCC---- | 41.43 | 25755297 | |
| 212 | Ubiquitination | SNFKSPVKTIR---- HCCCCCCCCCC---- | 41.43 | 21890473 | |
| 212 | Ubiquitination | SNFKSPVKTIR---- HCCCCCCCCCC---- | 41.43 | 21890473 | |
| 212 | Sumoylation | SNFKSPVKTIR---- HCCCCCCCCCC---- | 41.43 | - | |
| 212 | Acetylation | SNFKSPVKTIR---- HCCCCCCCCCC---- | 41.43 | 19608861 | |
| 213 | Phosphorylation | NFKSPVKTIR----- CCCCCCCCCC----- | 23.40 | 24732914 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 2 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
| 2 | S | Phosphorylation | Kinase | CSNK2A2 | P19784 | GPS |
| 2 | S | Phosphorylation | Kinase | CSK2B | P67870 | PhosphoELM |
| 2 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
| 2 | S | Phosphorylation | Kinase | CSNK2B | - | GPS |
| 2 | S | Phosphorylation | Kinase | CK2_GROUP | - | PhosphoELM |
| 3 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
| 3 | S | Phosphorylation | Kinase | CSNK2A2 | P19784 | GPS |
| 3 | S | Phosphorylation | Kinase | CSK2B | P67870 | PhosphoELM |
| 3 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
| 3 | S | Phosphorylation | Kinase | CSNK2B | - | GPS |
| 3 | S | Phosphorylation | Kinase | CK2_GROUP | - | PhosphoELM |
| 209 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 209 | S | Phosphorylation | Kinase | CDK-FAMILY | - | GPS |
| 209 | S | Phosphorylation | Kinase | CDK_GROUP | - | PhosphoELM |
| 213 | T | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CSK2B_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CSK2B_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-212, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-3; SER-4; SER-8;SER-69; THR-145; TYR-197; SER-205 AND SER-209, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-3; SER-4; SER-8;SER-69 AND SER-209, AND MASS SPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-209, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-3; SER-4 ANDSER-209, AND MASS SPECTROMETRY. | |